• E25.9 - Adrenogenital disorder, unspecified
  • E26.81 - Bartter's syndrome
  • D35.00 - Benign neoplasm of unspecified adrenal gland
  • E25.0 - Congenital adrenogenital disorders associated with enzyme deficiency
  • E26.01 - Conn's syndrome
  • E24.9 - Cushing's syndrome, unspecified
  • E26.02 - Glucocorticoid-remediable aldosteronism
  • E26.9 - Hyperaldosteronism, unspecified
  • E27.49 - Other adrenocortical insufficiency
  • E26.09 - Other primary hyperaldosteronism
  • E27.1 - Primary adrenocortical insufficiency
  • E26.1 - Secondary hyperaldosteronism
  • E27.40 - Unspecified adrenocortical insufficiency
  • E85.9 - Amyloidosis, unspecified
  • E85.2 - Heredofamilial amyloidosis, unspecified
  • E85.8 - Other amyloidosis
  • E85.3 - Secondary systemic amyloidosis
  • E87.2 - Acidosis
  • E87.0 - Hyperosmolality and hypernatremia
  • E16.2 - Hypoglycemia, unspecified
  • E15 - Nondiabetic hypoglycemic coma
  • E13.65 - Other specified diabetes mellitus with hyperglycemia
  • E13.9 - Other specified diabetes mellitus without complications
  • E10.65 - Type 1 diabetes mellitus with hyperglycemia
  • E10.10 - Type 1 diabetes mellitus with ketoacidosis without coma
  • E10.9 - Type 1 diabetes mellitus without complications
  • E11.65 - Type 2 diabetes mellitus with hyperglycemia
  • E11.69 - Type 2 diabetes mellitus with other specified complication
  • E11.9 - Type 2 diabetes mellitus without complications
  • E80.21 - Acute intermittent (hepatic) porphyria
  • E80.2 - Other and unspecified porphyria
  • E80.1 - Porphyria cutanea tarda
  • E87.2 - Acidosis
  • E86.0 - Dehydration
  • E83.52 - Hypercalcemia
  • E87.5 - Hyperkalemia
  • E83.41 - Hypermagnesemia
  • E87.0 - Hyperosmolality and hypernatremia
  • E87.1 - Hypo-osmolality and hyponatremia
  • E83.51 - Hypocalcemia
  • E87.6 - Hypokalemia
  • E83.42 - Hypomagnesemia
  • E86.1 - Hypovolemia
  • E83.39 - Other disorders of phosphorus metabolism
  • E87.79 - Other fluid overload
  • E86.9 - Volume depletion, unspecified
  • E31.21 - Multiple endocrine neoplasia [MEN] type I
  • E31.22 - Multiple endocrine neoplasia [MEN] type IIA
  • E31.23 - Multiple endocrine neoplasia [MEN] type IIB
  • E22.0 - Acromegaly and pituitary gigantism
  • E23.2 - Diabetes insipidus
  • E23.7 - Disorder of pituitary gland, unspecified
  • N64.3 - Galactorrhea not associated with childbirth
  • E23.0 - Hypopituitarism
  • E23.3 - Hypothalamic dysfunction, not elsewhere classified
  • E23.6 - Other disorders of pituitary gland
  • E31.0 - Autoimmune polyglandular failure
  • E31.20 - Multiple endocrine neoplasia [MEN] syndrome, unspecified
  • E31.8 - Other polyglandular dysfunction
  • E06.3 - Autoimmune thyroiditis
  • E03.1 - Congenital hypothyroidism without goiter
  • Q89.2 - Congenital malformations of other endocrine glands
  • E03.9 - Hypothyroidism, unspecified
  • C73 - Malignant neoplasm of thyroid gland
  • E04.0 - Nontoxic diffuse goiter
  • E04.2 - Nontoxic multinodular goiter
  • E04.1 - Nontoxic single thyroid nodule
  • E06.5 - Other chronic thyroiditis
  • E03.8 - Other specified hypothyroidism
  • E05.80 - Other thyrotoxicosis without thyrotoxic crisis or storm
  • E89.0 - Postprocedural hypothyroidism
  • E07.81 - Sick-euthyroid syndrome
  • E06.1 - Subacute thyroiditis
  • E06.9 - Thyroiditis, unspecified
  • E05.01 - Thyrotoxicosis with diffuse goiter with thyrotoxic crisis or storm
  • E05.00 - Thyrotoxicosis with diffuse goiter without thyrotoxic crisis or storm
  • E05.10 - Thyrotoxicosis with toxic single thyroid nodule without thyrotoxic crisis or storm
  • E05.91 - Thyrotoxicosis, unspecified with thyrotoxic crisis or storm
  • E05.90 - Thyrotoxicosis, unspecified without thyrotoxic crisis or storm